84 related articles for article (PubMed ID: 1556897)
1. Monocyte tumor necrosis factor production in head and neck squamous cell carcinoma.
Gallo O; Pinto S; Boccuzzi S; Dilaghi M; Gallina E; Attanasio M; Gori AM; Martini F; Abbate R
Laryngoscope; 1992 Apr; 102(4):447-50. PubMed ID: 1556897
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha production in human head and neck squamous cell carcinoma.
Parks RR; Yan SD; Huang CC
Laryngoscope; 1994 Jul; 104(7):860-4. PubMed ID: 7517483
[TBL] [Abstract][Full Text] [Related]
3. TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma.
Ikemoto S; Sugimura K; Yoshida N; Wada S; Yamamoto K; Kishimoto T
Anticancer Res; 2000; 20(1A):317-21. PubMed ID: 10769674
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
Milanovich MR; Snyderman CH; Wagner R; Johnson JT
Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
Kross KW; Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
Acta Otolaryngol; 2005 Oct; 125(10):1097-104. PubMed ID: 16298793
[TBL] [Abstract][Full Text] [Related]
6. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
7. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Olofsson J
Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
[TBL] [Abstract][Full Text] [Related]
10. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer.
Yoldas B; Ozer C; Ozen O; Canpolat T; Dogan I; Griffith TS; Sanlioglu S; Ozluoglu LN
Head Neck; 2011 Sep; 33(9):1278-84. PubMed ID: 21837697
[TBL] [Abstract][Full Text] [Related]
12. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection.
Heriot AG; Marriott JB; Cookson S; Kumar D; Dalgleish AG
Br J Cancer; 2000 Mar; 82(5):1009-12. PubMed ID: 10737381
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
14. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies.
Smith RE; Thornton DE; Allen J
Semin Oncol; 1995 Jun; 22(3 Suppl 6):41-6. PubMed ID: 7597432
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
Nieuwenhuis EJ; van der Waal I; Leemans CR; Kummer A; Pijpers R; Castelijns JA; Brakenhoff RH; Snow GB
Head Neck; 2005 Feb; 27(2):150-8. PubMed ID: 15627261
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
Su TR; Chang KL; Lee CH; Chen CH; Yang YH; Shieh TY
Oral Oncol; 2004 Sep; 40(8):804-10. PubMed ID: 15288835
[TBL] [Abstract][Full Text] [Related]
18. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
[TBL] [Abstract][Full Text] [Related]
19. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]